Dynamics of acute and memory mucosal and systemic immune responses against HIV-1 envelope following immunizations through single or combinations of mucosal and systemic routes. (Q51965192)

From Wikidata

Jump to navigation Jump to search

scientific article published on 26 December 2007

Language	Label	Description	Also known as
English	Dynamics of acute and memory mucosal and systemic immune responses against HIV-1 envelope following immunizations through single or combinations of mucosal and systemic routes.	scientific article published on 26 December 2007

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/18440102

Dynamics of acute and memory mucosal and systemic immune responses against HIV-1 envelope following immunizations through single or combinations of mucosal and systemic routes. (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/18440102

0 references

systemic immune response

1 reference

based on heuristic

inferred from title

author name string

Indresh Srivastava

1

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/18440102

Amanda Goodsell

2

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/18440102

Fengmin Zhou

3

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/18440102

Yi Sun

4

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/18440102

Brian Burke

5

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/18440102

Susan Barnett

6

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/18440102

Michael Vajdy

7

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/18440102

language of work or name

0 references

publication date

26 December 2007

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/18440102

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/18440102

26

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/18440102

22

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/18440102

2796-2806

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/18440102

Global burden of the HIV pandemic

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.083

7 January 2021

Functional HIV-1 specific IgA antibodies in HIV-1 exposed, persistently IgG seronegative female sex workers

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.083

7 January 2021

Mucosal and plasma IgA from HIV-1-exposed uninfected individuals inhibit HIV-1 transcytosis across human epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.083

7 January 2021

HIV-1-specific mucosal IgA in a cohort of HIV-1-resistant Kenyan sex workers

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.083

7 January 2021

The ability of an oligomeric human immunodeficiency virus type 1 (HIV-1) envelope antigen to elicit neutralizing antibodies against primary HIV-1 isolates is improved following partial deletion of the second hypervariable region

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.083

7 January 2021

Improved elicitation of neutralizing antibodies against primary human immunodeficiency viruses by soluble stabilized envelope glycoprotein trimers

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.083

7 January 2021

Mucosal vaccination strategies for women

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.083

7 January 2021

Mucosal adjuvanticity and immunogenicity of LTR72, a novel mutant of Escherichia coli heat-labile enterotoxin with partial knockout of ADP-ribosyltransferase activity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.083

7 January 2021

Intranasal immunization of mice with herpes simplex virus type 2 recombinant gD2: the effect of adjuvants on mucosal and serum antibody responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.083

7 January 2021

IgA antibody-forming cell responses in the nasal-associated lymphoid tissue of mice vaccinated by intranasal, intravenous and/or subcutaneous administration

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.083

7 January 2021

Proteosomes, emulsomes, and cholera toxin B improve nasal immunogenicity of human immunodeficiency virus gp160 in mice: induction of serum, intestinal, vaginal, and lung IgA and IgG.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.083

7 January 2021

Human immune responses to influenza virus vaccines administered by systemic or mucosal routes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.083

7 January 2021

Immunization of mice with recombinant gp41 in a systemic prime/mucosal boost protocol induces HIV-1-specific serum IgG and secretory IgA antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.083

7 January 2021

Vaccine regimen for prevention of sexually transmitted infections with human papillomavirus type 16.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.083

7 January 2021

Parenteral and mucosal prime-boost immunization strategies in mice with hepatitis B surface antigen and CpG DNA

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.083

7 January 2021

Prime-boost immunization with DNA vaccine: mucosal route of administration changes the rules

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.083

7 January 2021

Naked DNA when co-administered intranasally with heat-labile enterotoxin of Escherichia coli primes effectively for systemic B- and T-cell responses to the encoded antigen

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.083

7 January 2021

An experimental prime-boost regimen leading to HIV type 1-specific mucosal and systemic immunity in BALB/c mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.083

7 January 2021

Enhanced mucosal and systemic immune responses to Helicobacter pylori antigens through mucosal priming followed by systemic boosting immunizations.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.083

7 January 2021

A vaccination strategy to enhance mucosal and systemic antibody and T cell responses against influenza.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.083

7 January 2021

Mucosal and systemic anti-HIV responses in rhesus macaques following combinations of intranasal and parenteral immunizations

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.083

7 January 2021

Comparison of two immunization schedules with an inactivated hepatitis A vaccine (AvaximTM).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.083

7 January 2021

Mucosal vaccines: non toxic derivatives of LT and CT as mucosal adjuvants.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.083

7 January 2021

Purification, Characterization, and Immunogenicity of a Soluble Trimeric Envelope Protein Containing a Partial Deletion of the V2 Loop Derived from SF162, an R5-Tropic Human Immunodeficiency Virus Type 1 Isolate

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.083

7 January 2021

Phase I evaluation of intranasal trivalent inactivated influenza vaccine with nontoxigenic Escherichia coli enterotoxin and novel biovector as mucosal adjuvants, using adult volunteers

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.083

7 January 2021

Human immunodeficiency virus type 1 Gag-specific vaginal immunity and protection after local immunizations with sindbis virus-based replicon particles

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.083

7 January 2021

Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.083

7 January 2021

Induction of optimal immune responses against human immunodeficiency virus at mucosal portals of entry

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.083

7 January 2021

Generation and maintenance of mucosal memory B cell responses?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.083

7 January 2021

Comparison of the distribution of IgG and IgA antibodies in serum and various mucosal fluids of HIV type 1-infected subjects

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.083

7 January 2021

Modified wick method using Weck-Cel sponges for collection of human rectal secretions and analysis of mucosal HIV antibody

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.083

7 January 2021

Secretory component: a new role in secretory IgA-mediated immune exclusion in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.083

7 January 2021

Maintenance of long-term immunological memory by low avidity IgM-secreting cells in bone marrow after mucosal immunizations with cholera toxin adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.083

7 January 2021

Nasal absorption and biodistribution of plasmid DNA: an alternative route of DNA vaccine delivery

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.083

7 January 2021

Protective mucosal immunity in aging is associated with functional CD4+ T cells in nasopharyngeal-associated lymphoreticular tissue

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.083

7 January 2021

Induction of mucosal B-cell memory by intranasal immunization of mice with respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.083

7 January 2021

The olfactory route for cerebrospinal fluid drainage into the peripheral lymphatic system

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.083

7 January 2021

Characterization of human immunodeficiency virus Gag-specific gamma interferon-expressing cells following protective mucosal immunization with alphavirus replicon particles

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.083

7 January 2021

Challenges for vaccination against sexually-transmitted diseases: induction and long-term maintenance of mucosal immune responses in the female genital tract

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.083

7 January 2021

Increased level and longevity of protective immune responses induced by DNA vaccine expressing the HIV-1 Env glycoprotein when combined with IL-21 and IL-15 gene delivery

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.083

7 January 2021

Mucosa-associated lymphoid tissues in the aerodigestive tract: their shared and divergent traits and their importance to the orchestration of the mucosal immune system

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.083

7 January 2021

The role of adjuvants in the development of mucosal vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.083

7 January 2021

Specific-antibody-secreting cells in the rectums and genital tracts of nonhuman primates following vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.11.083

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2007.11.083

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/18440102

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 April 2018

http://europepmc.org/abstract/MED/18440102

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51965192&oldid=1404953630"